Log in to save to my catalogue

Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transitio...

Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transitio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2522399952

Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition

About this item

Full title

Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition

Publisher

New York: Springer US

Journal title

Medical oncology (Northwood, London, England), 2021-06, Vol.38 (6), p.66-66, Article 66

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Epithelial to mesenchymal transition (EMT) is a physiological process that assumes a primary role in the induction of cancer metastasis. This results in increased cell renewal, and resistance to cell death and therapies. EMT, therefore, represents an effective strategy for regulating cancerous cell activity. A need for efficacy and low cytotoxicity...

Alternative Titles

Full title

Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2522399952

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2522399952

Other Identifiers

ISSN

1357-0560

E-ISSN

1559-131X

DOI

10.1007/s12032-021-01508-8

How to access this item